Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Oxford is to take part in three new government-funded projects designed to help universities collaborate with each other, and with external organisations, to boost research commercialisation.

None

Image courtesy of Shutterstock

Healthy ageing, the internet of things, and commercialisation in the social sciences are the three themes with involvement from Oxford academics. Oxford is leading the programme on healthy ageing, is a partner in the Sheffield University-led internet of things project, and will also participate in the social sciences initiative led by LSE.

The projects are funded via Research England (formerly the Higher Education Funding Council for England) through its Connecting Capability Fund (CCF). This £100m fund supports university collaboration in research commercialisation with the aims of sharing good practice across the higher education sector, forging external technological, industrial and regional partnerships, and helping deliver the government's industrial strategy priorities.

Oxford recently launched its 150th spinout company based on University research. In 2018 alone, six new companies have been formed and more than £150m has been raised in external investment.

Professor Chas Bountra of Oxford's Nuffield Department of Clinical Medicine is leading the healthy ageing programme, titled UK SPINE KE and also involving Birmingham and Dundee universities. Announced last autumn in the first wave of CCF awards, the £4.82m project will establish a UK-wide network across universities, businesses and the NHS focused on improving health in old age.

Find out more (University of Oxford website)

Similar stories

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.

Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK study

COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.

COVID-19’s high blood clot risk

A recent study of patient health records found that around 1 in 100 people with COVID-19 had a venal or arterial thrombosis, with rates higher still among males, and particularly for those hospitalised.

Medical Sciences Division receives REF 2021 results

Today the UK Funding Bodies have published the outcomes of the recent national research assessment exercise, the Research Excellence Framework (REF) 2021. REF is the UK-wide assessment of research in universities, and provides an expert evaluation of the quality of the research outputs, impact and environment at subject level in each university.